Status:
TERMINATED
Xenon and Therapeutical Hypothermia After Successful Cardiopulmonary Resuscitation
Lead Sponsor:
RWTH Aachen University
Conditions:
Efficacy and Safety of Xenon Inhalation
Successful Cardiopulmonary Resuscitation
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
In this clinical trial will be checked, whether 2 hour ventilation with xenon has neuroprotective effects in patients with out of hospital cardiac arrest and successful cardiopulmonary resuscitation
Detailed Description
Patients with out of hospital cardiac arrest and successful cardiopulmonary resuscitation will be randomized in two groups. First group (Treatment group) will be inhalated with xenon within 2 hours in...
Eligibility Criteria
Inclusion
- Patients with out of hospital cardiac arrest and successful cardiopulmonary resuscitation, which will be treated at Department of Internal Medicine I, University Hospital Aachen
Exclusion
- Patients younger than 18 years
- Xenon allergy
- Pregnancy
- High expired oxygen requirement (\>70%) in order to maintain adequate arterial oxygen saturation (SpO2\>94%) at the beginning of treatment
Key Trial Info
Start Date :
September 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2014
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT01262729
Start Date
September 1 2011
End Date
December 1 2014
Last Update
September 23 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Surgical Intensive Care - Adults, University Hospital Aachen
Aachen, North Rhine-Westphalia, Germany, 52074